Company news
Solid Biosciences Inc. news in 2023
Solid Biosciences Inc.'s news releases, calls and decks from 2023, newest first.
Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003
December 6, 2023
Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
November 13, 2023
Solid Biosciences Provides Third Quarter Business Update and Financial Results
November 7, 2023
Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer
October 1, 2023
Solid Biosciences Provides Second Quarter Business Update and Financial Results
August 13, 2023
Solid Biosciences Provides First Quarter Business Update and Financial Results
May 10, 2023
Solid Biosciences Provides Fourth Quarter and Full-Year 2022 Business Update and Financial Results
March 22, 2023
Solid Biosciences and Phlox Therapeutics Announce Strategic Research Collaboration Focused on Accelerating the Development of New Therapies for Rare Cardiac Diseases
January 10, 2023
Solid Biosciences Reports Inducement Grant to Chief Financial Officer and Treasurer
January 8, 2023
Solid Biosciences Appoints Kevin Tan, CFA, as Chief Financial Officer
January 8, 2023
Decks in 2023
- 41st Annual J.P. Morgan Healthcare Conference (January 2023)
Conference · 27 slides · Jan 9, 2023